Vnitr Lek 2017, 63(1):22-23 | DOI: 10.36290/vnl.2017.004

Progresivní multifokální leukoencefalopatie - editorial

Pavel Polák
Oddělení klinické hematologie FN Brno

Received: March 21, 2016; Published: January 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Polák P. Progresivní multifokální leukoencefalopatie - editorial. Vnitr Lek. 2017;63(1):22-23. doi: 10.36290/vnl.2017.004.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Padgett BL, Walker DL, ZuRhein GM et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1(7712): 1257-1260. Go to original source... Go to PubMed...
    2. Ferenczy MW, Marshall LJ, Nelson ChDS et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 2012; 25(3): 471-506. Dostupné z DOI: <http://dx.doi.org/10.1128/CMR.05031-11>. Go to original source... Go to PubMed...
    3. Monaco MC, Major EO. Immune system involvement in the pathogenesis of JC virus induced PML: what is learned from studies of patients with underlying diseases and therapies as risk factors. Front Immunol 2015; 6:159. Dostupné z DOI: <http://dx.doi.org/10.3389/fimmu.2015.00159>. Go to original source... Go to PubMed...
    4. Kornek B. An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations. Patient Prefer Adherence 2015; 9: 675-684. Dostupné z DOI: <http://dx.doi.org/10.2147/PPA.S20791>. Go to original source... Go to PubMed...
    5. Berger JR, Sidney MD, Houff MD et al. JC virus antibody status underestimates infection rates. Ann Neurol 2013; 74(1): 84-90. Dostupné z DOI: <http://dx.doi.org/10.1002/ana.23893>. Go to original source... Go to PubMed...
    6. Nakamichi K, Mizusawa H, Yamada M et al. Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan. BMC Neurol 2012; 12: 121. Dostupné z DOI: <http://dx.doi.org/10.1186/1471-2377-12-121>. Go to original source... Go to PubMed...
    7. Fox R Advances in the management of PML: focus on natalizumab. Cleve Clin J Med 2011; 78(Suppl 2): S33-S37. Dostupné z DOI: <http://dx.doi.org/10.3949/ccjm.78.s2.08>. Go to original source... Go to PubMed...
    8. Kister I, Kuesters G, Chamot E et al. IV immunoglobulin confounds JC virus antibody serostatus determination. Neurol Neuroimmunol Neuroinflammation 2014; 1(3): e29. Dostupné z DOI: <http://dx.doi.org/10.1212/NXI.0000000000000029>. Go to original source... Go to PubMed...
    9. Bozic C, Subramanyam M, Richman S et al. Anti-JC virus (JCV) antibody prevalence in the JCV epidemiology in MS (JEMS) trial. Eur J Neurol 2014; 21(2): 299-304. Dostupné z DOI: <http://dx.doi.org/10.1111/ene.12304>. Go to original source... Go to PubMed...
    10. Rossi F, Newsome SD, Viscidi R Molecular diagnostic tests to predict the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients. Mol Cell Probes 2015; 29(1): 54-62. Dostupné z DOI: <http://dx.doi.org/10.1016/j.mcp.2014.11.007>. Go to original source... Go to PubMed...
    11. Štětkářová I, Medová E, Bučilová V et al. Progresivní multifokální leukoencefalopatie u nemocné s roztroušenou sklerózou léčenou natalizumabem. Čes Radiol 2013; 67(1): 35-38.
    12. Vališ M, Belada D, Taláb R et al. Progresivní multifokální leukoencefalopatie jako komplikace léčby lymfomu - kazuistika. Česk Slov Neurol N 2009; 72/105(2): 159-161.
    13. Táborský P, Hrabánek J, Jirásek A et al. Progresivní multifokální leukoencefalopatie u nemocné po transplantaci ledviny. Vnitř Lék 1998; 44(2): 108-110. Go to PubMed...
    14. Horáková D, Havrdová E. Protilátky proti JC viru a stratifikace rizika progresivní multifokální leukoencefalopatie u pacientů s roztroušenou sklerózou. Doporučení k použití nového testu STRATIFY JCVTM. Neurol praxi 2011; 12(5): 364-365.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.